Consultancies and service providers at Festival of Biologics 2026
Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website
27 consultancies and service providers are at Festival of Biologics 2026 — 32 presentations on the program and 5 with a booth in the exhibit hall. Most represented: ACLRT.Bio (3 on the program), HINA Bioventures (2 on the program), LYO-X (2 on the program). 13 of them have their own page in this guide. As of Sep 26, 2026.
Topic
Top represented
Showing 1–16 of 27 organizations
| Organization | Festival of Biologics 2026 Attendance |
|---|---|
AB ACLRT.Bio | |
Biotech-as-a-service company giving early-stage oncology and immunology developers senior-led development execution from lead optimization to proof of concept. | Talk Wed Oct 14 12:30 The Biotech Efficiency Gap: Why Building from Scratch is Costing the Clinic Billions Why disbanding drug development teams after an exit or a failure wastes money, given only 20% of assets reach proof of concept. |
Panel Tue Oct 13 15:10 Panel Discussion: From Research to GMP: Making MSC Manufacturing Reproducible at Scale How to grow mesenchymal stromal cells, a kind of stem cell, the same way batch after batch as production scales up. Talk Wed Oct 14 16:50 Talk Thu Oct 15 12:20 Bioprocessing 4.0: From Data Infrastructure to Autonomous Biomanufacturing How reusable manufacturing data could lead to self-optimizing labs and factories, and why drug makers, contract manufacturers and investors must cooperate. | |
LX | |
Pharmacometrics consultancy offering PK/PD and quantitative systems pharmacology modelling for drug development. | Talk Tue Oct 13 13:30 First in Human Dose Selection for ADCs and TCEs Using PK/PD and QSP How computer models of drug behavior help pick safe yet active first human doses for antibody–drug conjugates and T cell engagers. Clinical developmentADCs & armed antibodies Chair Tue Oct 13 16:45 |
Pathways Preclinical Partners Newark, DE | |
Consultancy guiding drug developers from late preclinical research to first-in-human trials, covering preclinical and regulatory strategy and study support. | Chair Wed Oct 14 16:45 Panel Wed Oct 14 17:10 Panel Wed Oct 14 17:50 |
Swiss drug discovery and development incubator that also provides chief medical officer services to start-up and small biopharmaceutical companies. | Panel Tue Oct 13 17:30 Keynote Thu Oct 15 09:55 Braving the new world : Biosimilars in the post-CES era. What changes for biosimilars, copies of biologic drugs, as regulators grow willing to accept them without a costly comparison trial in patients. |
Panel Wed Oct 14 17:10 Panel Wed Oct 14 17:50 | |
Inveready Barcelona, Spain | |
Spanish venture capital firm investing in life sciences and technology companies. | Panel Wed Oct 14 17:10 Panel Wed Oct 14 17:50 |
Panel Tue Oct 13 17:30 | |
Venture capital firm investing in life science start-ups. | Panel Wed Oct 14 17:10 Panel Wed Oct 14 17:50 |
A Arthama | |
Talk Tue Oct 13 15:10 | |
A awoCON | |
Talk Wed Oct 14 15:10 Advancing the Development of Biologics with NAMs How human-based methods such as lab-grown tissues, organ-on-chip systems and computer models can cut animal testing when judging biologic drug safety. | |
BF BioFund Family Office | |
Talk Wed Oct 14 11:50 What the Biology Can't Fix Good science doesn't automatically become good medicine. Some things have to be right before the biology even gets its chance How separate research and development timelines, data from treating cancer in pets, and funding choices decide which promising biologics survive. | |
B BioTalent | |
Talk Wed Oct 14 11:50 The Science of Talent in Biopharma – Measuring Human Performance as a Strategic Asset How data models measure the readiness of biopharma workers and tie it to productivity and quality, with a view of European skills gaps. | |
BC BL Consulting | |
Panel Wed Oct 14 15:10 | |
C Complyomics | |
Panel Wed Oct 14 17:30 PANEL DISCUSSION: From Contract to Collaboration: Effective CDMO Strategies for Biopharma Manufacturing How drug makers and contract manufacturers can work as true partners, sharing process know-how and handling changes as production scales up. |
Instantly find 20 buyers from consultancies and service providers
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse Festival of Biologics 2026 by
Organization type
Topic
- Antibody & protein engineering 67
- AI & computational design 38
- Bispecifics & multispecifics 13
- ADCs & armed antibodies 18
- Immunotherapy & oncology 44
- Cell & gene therapy 28
- Therapeutic vaccines 13
- Peptides & GLP-1 7
- Bioprocessing & manufacturing 87
- CMC, formulation & analytics 58
- Clinical development 45
- Regulation & market access 40
Exhibit hall
Everyone
Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction